KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Feb 10, 2016 $12.32 $12.32 $12.32 $12.32 159 400
Feb 09, 2016 $12.06 $12.06 $12.06 $12.06 297 400
Feb 08, 2016 $13.10 $13.10 $13.10 $13.10 95 800
Feb 05, 2016 $14.15 $14.15 $14.15 $14.15 89 500
Feb 04, 2016 $14.46 $14.46 $14.46 $14.46 58 000
Feb 03, 2016 $14.36 $14.36 $14.36 $14.36 71 400
Feb 02, 2016 $14.74 $14.74 $14.74 $14.74 76 500
Feb 01, 2016 $14.66 $14.66 $14.66 $14.66 132 300
Jan 29, 2016 $14.61 $14.61 $14.61 $14.61 106 100
Jan 28, 2016 $14.56 $14.56 $14.56 $14.56 138 000
Jan 27, 2016 $15.07 $15.07 $15.07 $15.07 74 800
Jan 26, 2016 $15.91 $15.91 $15.91 $15.91 73 700
Jan 25, 2016 $16.11 $16.11 $16.11 $16.11 131 800
Jan 22, 2016 $15.83 $15.83 $15.83 $15.83 101 700
Jan 21, 2016 $15.01 $15.01 $15.01 $15.01 90 500
Jan 20, 2016 $15.38 $15.38 $15.38 $15.38 191 800
Jan 19, 2016 $14.42 $14.42 $14.42 $14.42 169 000
Jan 15, 2016 $15.55 $15.55 $15.55 $15.55 157 800
Jan 14, 2016 $14.72 $14.72 $14.72 $14.72 366 800
Jan 13, 2016 $14.62 $14.62 $14.62 $14.62 120 000
Jan 12, 2016 $15.84 $15.84 $15.84 $15.84 159 500
Jan 11, 2016 $16.01 $16.01 $16.01 $16.01 232 100
Jan 08, 2016 $17.01 $17.01 $17.01 $17.01 238 800
Jan 07, 2016 $17.42 $17.42 $17.42 $17.42 229 000
Jan 06, 2016 $19.23 $19.23 $19.23 $19.23 129 600
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT